Galactokinase
From Proteopedia
(Difference between revisions)
| Line 25: | Line 25: | ||
[[6q91]] - hGALK + benzamide derivative + gal<br /> | [[6q91]] - hGALK + benzamide derivative + gal<br /> | ||
[[6q90]], [[6zgw]] - hGALK + pyridine derivative + gal<br /> | [[6q90]], [[6zgw]] - hGALK + pyridine derivative + gal<br /> | ||
| - | [[6q3x]] - hGALK + quinazoline derivative + gal<br /> | + | [[6q3x]], [[6zfh]] - hGALK + quinazoline derivative + gal<br /> |
[[6zgv]], [[6zgx]], [[6zgz]], [[6zgy]] - hGALK + pyrimidine derivative + gal<br /> | [[6zgv]], [[6zgx]], [[6zgz]], [[6zgy]] - hGALK + pyrimidine derivative + gal<br /> | ||
[[6qje]] - hGALK + imidazole derivative + gal<br /> | [[6qje]] - hGALK + imidazole derivative + gal<br /> | ||
Revision as of 08:02, 2 August 2021
| |||||||||||
References
- ↑ Holden HM, Thoden JB, Timson DJ, Reece RJ. Galactokinase: structure, function and role in type II galactosemia. Cell Mol Life Sci. 2004 Oct;61(19-20):2471-84. doi: 10.1007/s00018-004-4160-6. PMID:15526155 doi:http://dx.doi.org/10.1007/s00018-004-4160-6
- ↑ Timson DJ, Reece RJ. Functional analysis of disease-causing mutations in human galactokinase. Eur J Biochem. 2003 Apr;270(8):1767-74. PMID:12694189
- ↑ Thoden JB, Timson DJ, Reece RJ, Holden HM. Molecular structure of human galactokinase: implications for type II galactosemia. J Biol Chem. 2005 Mar 11;280(10):9662-70. Epub 2004 Dec 7. PMID:15590630 doi:10.1074/jbc.M412916200
